Baylor researcher awarded a Marie Curie Global Fellowship
Dr. Bjoern Burckhardt will use mass spectrometric imaging to identify potential new biomarkers and promising drug targets for human diseases.
Read More
Interferon drives cognitive impairment in Alzheimer’s disease model
This study highlights the importance of brain inflammation and other complex events involved in the development of Alzheimer’s disease.
Read More
The discovery of genes like PAX5 improves diagnostic testing for neurodevelopmental disorders, and more
Discovering new genes that are linked to undiagnosed diseases has relevant scientific and clinical consequences as well as important personal implications for patients.
Read More
April is National Autism Awareness Month
From the Labs presents a sample of Baylor’s basic research work contributing to a better understanding of autism and related disorders.
Read More
Researchers identify two distinct tuberculosis subtypes – one has better prognosis than the other
The study of the human immune response to tuberculosis revealed an approach that can lead to the development of personalized therapies.
Read More
Video of the Month: A cell dividing
Cell division is a highly dynamic and energy-demanding process.
Read More
Estrogen-regulated brain circuit helps females control obesity
An estrogen-activated brain circuit connects specific brain regions, providing anti-obesity benefits in an animal model.
Read More
Oleic acid, a key to activating the brain’s ‘fountain of youth’
Oleic acid produced in the brain is an essential regulator of the process that enables learning and memory and proper mood regulation.
Read More
Tuberculosis induces premature cellular aging
It’s possible that premature cellular aging in TB is one reason why survivors have a three-fold increased risk of mortality.
Read More
Targeting TGF-β for treatment of osteogenesis imperfecta
A monoclonal antibody therapy that neutralizes TGF-β produced promising results in a Phase 1 clinical trial.
Read More